| BMS754807 |
|
| (CAS 1001350-96-4) |
 |
| Description： |
BMS-754807 is an orally bioavailable antagonist of human insulin-like growth factor type I receptor (IGF-1R) with potential antineoplastic activity. IGF-1R antagonist BMS-7548077 binds to IGF-1R, preventing IGF-1 ligand binding and activation of IGF-1R-mediated signaling pathways; inhibition of IGF-1R-mediated signaling pathways may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. IGF-1R is a receptor tyrosine kinase expressed on most tumor cells and is involved in mitogenesis, angiogenesis, and tumor cell survival.
|
| Product No. |
KT00210 |
| Product Name |
BMS754807 |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
1001350-96-4 |
| Molecular Formula |
C23H24FN9O |
| Formula Weight |
C23H24FN9O |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
AG1024
AXL1717
AZD-3463
BMS-536924
GSK1838705A
GSK1904529A
KU14R
NVP-ADW742
|
|
